{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:11:55Z","timestamp":1788718315386,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.leu.2402550","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T10:59:36Z","timestamp":1035197976000},"page":"1423-1431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation"],"prefix":"10.1038","volume":"16","author":[{"given":"JA","family":"P\u00e9rez-Sim\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Diez-Campelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lopez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Vidriales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,31]]},"reference":[{"key":"BF2402550_CR1","unstructured":"Advisory Committee of the International Bone Marrow Transplant Registry. Report from the International Bone Marrow Transplant Registry Bone Marrow Transplant 1989 48: 453\u2013458"},{"key":"BF2402550_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/jama.1992.03490050055025","volume":"268","author":"MM Bortin","year":"1992","unstructured":"Bortin MM, Horowitz MM, Gale RP, Barret AJ, Champlin RE, Dicke KA, Gluckman E, Kolb HJ, Marmont AM, Mrsic M . Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s JAMA 1992 268: 607\u2013612","journal-title":"JAMA"},{"key":"BF2402550_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"JO Armitage","year":"1994","unstructured":"Armitage JO . Bone marrow transplantation N Engl J Med 1994 330: 827\u2013838","journal-title":"N Engl J Med"},{"key":"BF2402550_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1365-2141.2000.02075.x","volume":"110","author":"S Mackinnon","year":"2000","unstructured":"Mackinnon S . Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation? Br J Haematol 2000 110: 12\u201317","journal-title":"Br J Haematol"},{"key":"BF2402550_CR5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R . Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"},{"key":"BF2402550_CR6","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, K\u00f6rbling M, Keating M, Kantarjian H, Champlin R . Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy Blood 1997 89: 4531\u20134536","journal-title":"Blood"},{"key":"BF2402550_CR7","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","volume":"89","author":"R Storb","year":"1997","unstructured":"Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H . Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation Blood 1997 89: 3048\u20133054","journal-title":"Blood"},{"key":"BF2402550_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-642-60377-8_51","volume-title":"Acute Leukemias VI","author":"J. F. San Miguel","year":"1997","unstructured":"San Miguel JF, van Dongen JJM . Methods for detection of minimal residual disease In: Buchner T et al (eds) Acute Leukemias VI. Springer Verlag: Berlin 1997 pp 307\u2013312"},{"key":"BF2402550_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1056\/NEJM199401133300204","volume":"330","author":"DL Porter","year":"1994","unstructured":"Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH . Induction of graft versus host disease as immunotherapy for relapsed chronic myeloid leukemia N Engl J Med 1994 330: 100\u2013106","journal-title":"N Engl J Med"},{"key":"BF2402550_CR10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B . Graft versus leukemia reactions after bone marrow transplantation Blood 1990 75: 555\u2013562","journal-title":"Blood"},{"key":"BF2402550_CR11","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"PL Weiden","year":"1981","unstructured":"Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED . Antileukemic effect of chronic graft versus host disease: contribution to improved survival after allogeneic marrow transplantation N Engl J Med 1981 304: 1529\u20131533","journal-title":"N Engl J Med"},{"key":"BF2402550_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J . Donor leukocyte infusions in 140 patients relapsed with malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433\u2013444","journal-title":"J Clin Oncol"},{"key":"BF2402550_CR13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D . Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF2402550_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.leu.2400546","volume":"11","author":"H Bertz","year":"1997","unstructured":"Bertz H, Burger JA, Kunzmann R, Mertelsmann R, Finke J . Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft versus myeloma effect Leukemia 1997 11: 281\u2013283","journal-title":"Leukemia"},{"key":"BF2402550_CR15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EP, Carabasi MH, Reich L, Collins NH, Poulad F, Castro-Malaspina H, Childs BH, Gilio AP, Kernan NA, Small TN, Young JW, O'Reilly RJ . Adoptive immunotherapy evaluating escalating doses of donor leucocytes for relapse of chronic myeloic leukemia following bone marrow transplantation: separation of graft versus leukemia responses from graft versus host disease Blood 1995 86: 1261\u20131268","journal-title":"Blood"},{"key":"BF2402550_CR16","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood.V83.11.3409.3409","volume":"83","author":"S Mackinnon","year":"1994","unstructured":"Mackinnon S, Barnett L, Heller G, O'Reilly RJ . Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 3409\u20133416","journal-title":"Blood"},{"key":"BF2402550_CR17","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood.V84.12.4385.bloodjournal84124385","volume":"83","author":"E Roux","year":"1994","unstructured":"Roux E, Helg C, Chapuis B . Mixed chimerism after bone marrow transplantation and the risk of relapse Blood 1994 83: 4385\u20134386","journal-title":"Blood"},{"key":"BF2402550_CR18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1182\/blood.V82.6.1921.1921","volume":"82","author":"JEM van Leeuwen","year":"1993","unstructured":"van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Khan PM, Vossen JM . Mixed T-lymphoid chimerim after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse Blood 1993 82: 1921\u20131928","journal-title":"Blood"},{"key":"BF2402550_CR19","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood.V80.12.3235.3235","volume":"80","author":"S Mackinnon","year":"1992","unstructured":"Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ . Myeloid and lymphoid chimaerism after T-cell depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA Blood 1992 80: 3235\u20133241","journal-title":"Blood"},{"key":"BF2402550_CR20","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood.V83.10.3059.3059","volume":"83","author":"JEM van Leeuwen","year":"1994","unstructured":"van Leeuwen JEM, van Tol MJD, Joosten AM, Wijnen JT, Verweij PJ, Khan PM, Vossen JM . Persistence of host type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and\/or the conditioning regimen, but is not associated with an increased risk of relapse Blood 1994 83: 3059\u20133067","journal-title":"Blood"},{"key":"BF2402550_CR21","doi-asserted-by":"crossref","unstructured":"Quantitative analysis of chimerism after allogeneic stem cell transplant using multiple PCR amplification of short tandem repeat markers and fluorescence detection. Appendix: method in focus Leukemia 2001 15: 303\u2013306","DOI":"10.1038\/sj.leu.2402008"},{"key":"BF2402550_CR22","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJM van Dongen","year":"1999","unstructured":"van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, D\u00edaz MG, Malec M, Langerak AW, San Miguel JF, Biondi A . Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease Leukemia 1999 13: 1901\u20131928","journal-title":"Leukemia"},{"key":"BF2402550_CR23","first-page":"162","volume":"86","author":"MC Chill\u00f3n","year":"2001","unstructured":"Chill\u00f3n MC, Garc\u00eda-Sanz R, Balanzategui A, Ramos F, Fern\u00e1ndez-Calvo J, Rodriguez MJ, Rodriguez-Salazar MI, Corrales A, Calmuntia MJ, Orfao A, Gonz\u00e1lez M, San Miguel JF . Molecular characterization of acute myeloblastic leukemia according to the new WHO classification : a different distribution in Central-West Spain Haematologica 2001 86: 162\u2013166","journal-title":"Haematologica"},{"key":"BF2402550_CR24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.V90.6.2465","volume":"90","author":"JF San Miguel","year":"1997","unstructured":"San Miguel JF, Mart\u00ednez A, Macedo A, Vidriales MB, L\u00f3pez-Berges C, Gonzalez M, Caballero D, Gac\u00eda-Marcos MA, Ramos F, Pern\u00e1ndez-Calvo J, Calmuntia MJ, Diaz-Mediavill J, Orfao A . Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients Blood 1997 90: 2465\u20132470","journal-title":"Blood"},{"key":"BF2402550_CR25","first-page":"299","volume":"6","author":"JF San Miguel","year":"1998","unstructured":"San Miguel JF, Almeida J, Ocqueteau M, Mateo G, Caballero MD, Garc\u00eda-Sanz R, Gonz\u00e1lez M, Corral M, Blad\u00e9 J, Hern\u00e1ndez JM, Orfao A . Immunophenotyping and DNA ploidy analysis for detection of Minimal Residual Disease in MM Cancer Res Ther Control 1998 6: 299\u2013302","journal-title":"Cancer Res Ther Control"},{"key":"BF2402550_CR26","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","volume":"16","author":"J Ciudad","year":"1998","unstructured":"Ciudad J, San Miguel JF, L\u00f3pez-Berges MC, Vidrials B, Valverde B, Ocqueteau M, Caballero MD, Hernandez J, Moro MJ, Mateos MV, Orfao A . Prognostic value of immunophenotypic detection of minimal residula disease in acute lymphoblastic leukemia J Clin Oncol 1998 16: 3774\u20133781","journal-title":"J Clin Oncol"},{"key":"BF2402550_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1040-8428(99)00032-3","volume":"32","author":"JF San Miguel","year":"1999","unstructured":"San Miguel JF, Ciudad J, Vidriales MB, Orfao A, Lucio P, Porwitt MacDonald A . Immunophenotypical detection of minimal residual disease in acute leukemia Crit Rev Oncol Hematol 1999 32: 175\u2013185","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF2402550_CR28","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V82.7.1954.1954","volume":"82","author":"R Clift","year":"1993","unstructured":"Clift R, Appelbaum F, Thomas E . Treatment of chronic myeloid leukemia by marrow transplantation Blood 1993 82: 1954\u20131956","journal-title":"Blood"},{"key":"BF2402550_CR29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V67.3.770.770","volume":"65","author":"HG Klingemann","year":"1986","unstructured":"Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum F, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, Whitherspoon RP, Thomas ED . Bone marrow transplantation in patients aged 45 years and older Blood 1986 65: 770\u2013776","journal-title":"Blood"},{"key":"BF2402550_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1993.03510010063030","volume":"270","author":"O Ringden","year":"19193","unstructured":"Ringden O, Horwitz MH, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM . Outcome after allogeneic bone marrow transplantation for leukemia in older patients JAMA 193 270: 57\u201360","journal-title":"JAMA"},{"key":"BF2402550_CR31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1200\/JCO.1986.4.10.1489","volume":"4","author":"KG Blumme","year":"1986","unstructured":"Blumme KG, Forman SJ, Nademanee AP, O'Donnell MR, Snyder DS, Fahey JL, Findley DO, Lipsett JA, Zaia JA, Metter GE, Hill LR . Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older J Clin Oncol 1986 4: 1489\u20131492","journal-title":"J Clin Oncol"},{"key":"BF2402550_CR32","first-page":"155","volume":"11","author":"S Slavin","year":"1981","unstructured":"Slavin S, Weiss L, Morecki S, Weigensberg M . Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation Cancer Immunother 1981 11: 155\u2013158","journal-title":"Cancer Immunother"},{"key":"BF2402550_CR33","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"PD Kottaridis","year":"2000","unstructured":"Kottaridis PD, Milligan D, Chopra R, Chakraverty R, Chakrabarti S, Robinson S, Peggs K, Verfuerth S, Pettengell R, Marsh JC, Schey MS, Mahendra P, Morgan GJ, Hale G, Waldmann H, Ruiz de Elvira C, Williams CD, Devereux S, Linch D . In vivo CAMPATH-1H prevents graft-versus-host diease following nonmyeloablative stem cell transplantation Blood 2000 96: 2419\u20132425","journal-title":"Blood"},{"key":"BF2402550_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall P, Khouri I, Wang X, Braunschweig I, Ippolitti C, Claxton D, Donato M, Bruton J, Cohen A, Davis M, Andersson BS, Anderlini P, Gajewski J, Kornblau S, Andreeff M, Przepiorka D, Ueno NT, Molldrem J, Champlin R . Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 2001 97: 631\u2013637","journal-title":"Blood"},{"key":"BF2402550_CR35","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Anseri H . Graft versus myeloma effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood ad Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF2402550_CR36","first-page":"124","volume-title":"Bone Marrow Transplantation","author":"NA Kernan","year":"1994","unstructured":"Kernan NA . T-cell depletion for prevention of graft versus host disease In: Forman SJ, Blume KG, Thomas ED (eds) Bone Marrow Transplantation Blackwell Scientific Publications: Boston, MA 1994 p 124"},{"key":"BF2402550_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bmt.1700861","volume":"20","author":"N Gardiner","year":"1997","unstructured":"Gardiner N, Lawler M, O'Riordan J, DeArce M, Humphries P, McCann SR . Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukemia Bone Marrow Transplant 1997 20: 235\u2013241","journal-title":"Bone Marrow Transplant"},{"key":"BF2402550_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1365-2141.2000.02110.x","volume":"109","author":"R W\u00e4sch","year":"2000","unstructured":"W\u00e4sch R, Bertz H, Kunzmann R, Finke J . Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation Br J Haematol 2000 109: 743\u2013750","journal-title":"Br J Haematol"},{"key":"BF2402550_CR39","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"P McSweeney","year":"2001","unstructured":"McSweeney P, Niederwieser D, Shizuru J, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radish J, Wagner JL, Minor S, Appelbaum F, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume K, Storb R . Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high dose cytotoxic therapy with graft versus tumor effect Blood 2001 97: 3390\u20133400","journal-title":"Blood"},{"key":"BF2402550_CR40","first-page":"1745","volume":"94 (Suppl. 1)","author":"A Molina","year":"1999","unstructured":"Molina A, McSweeny P, Maloney DG, Sandmaier B, Wagner JL, Nash RA, Chauncey T, Bryant E, Storb R . Degree of early donor T-cell chimerism predicts GVHD and graft rejection in patients with non-myeloablative hematopoietic sem cell allografts Blood 1999 94 (Suppl. 1): 1745","journal-title":"Blood"},{"key":"BF2402550_CR41","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1182\/blood.V89.7.2602","volume":"89","author":"J Radish","year":"1997","unstructured":"Radish J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas ED, Appelbaum F . Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation Blood 1997 89: 2602\u20132609","journal-title":"Blood"},{"key":"BF2402550_CR42","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V85.9.2632.bloodjournal8592632","volume":"85","author":"J Radish","year":"1995","unstructured":"Radish J, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P, Schoch G, Buckner CD, Sullivan KM, Appelbaum F, Thomas ED . Polymerase chain reaction detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients Blood 1995 85: 2632\u20132638","journal-title":"Blood"},{"key":"BF2402550_CR43","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","volume":"94","author":"R Childs","year":"1999","unstructured":"Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, Read EJ, Carter C, Bahceci E, Young NS, Barret AJ . Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses Blood 1999 94: 3234\u20133241","journal-title":"Blood"},{"key":"BF2402550_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"W Bensinger","year":"2001","unstructured":"Bensinger W, Martin P, Storer B, Clift R, Forman S, Negrin R, Kashyap A, Flowers Mlilleby K, Chauncey T, Storb R, Appelbaum F . Transplantation of bone marrow as compared with peripheral blood cells from HLA identical relatives in patients with hematologic cancers N Engl J Med 2001 344: 175\u2013181","journal-title":"N Engl J Med"},{"key":"BF2402550_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","volume":"18","author":"D Blaise","year":"2000","unstructured":"Blaise D, Kuentz M, Fortanier C, Bourhis J, Milpied N, Sutton L, Jouet JP, Attal M, Bordigoni P, Cahn JY, Boiron JM, Schuller MP, Moatti JP, Michallet M . Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early stage leukemia: a report from the Societe Francaise de Greffe de Moelle J Clin Oncol 2000 18: 537\u2013546","journal-title":"J Clin Oncol"},{"key":"BF2402550_CR46","first-page":"250","volume":"28","author":"K Sullivan","year":"1991","unstructured":"Sullivan K, Agura E, Anasetti C . Chronic graft versus host disease in other late complications of bone marrow transplantation Semin Hematol 1991 28: 250\u2013259","journal-title":"Semin Hematol"},{"key":"BF2402550_CR47","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/sj.leu.2401581","volume":"13","author":"P Bader","year":"1999","unstructured":"Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, Niethammer D, Beck JF . Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children Leukemia 1999 13: 2079\u20132086","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402550","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:35:48Z","timestamp":1648762548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,31]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF2402550"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402550","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,31]]},"assertion":[{"value":"23 May 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}